Search the Newsreel

John Rogers's Top Q2 2026 Move: Haemonetics Corp at a 1.54% Portfolio Impact

John Rogers, founder of Ariel Investment, LLC, submitted his Q2 2026 13F filing, revealing strategic portfolio adjustments. His top new buy was Haemonetics Corp (NYSE:HAE), making a 1.54% portfolio impact, alongside significant increases in RLI Corp (NYSE:RLI) and Masco Corp (NYSE:MAS). Rogers also completely …

HAE Stock Gains on Q1 Earnings & Revenue Beat, Fiscal '27 View Up

Haemonetics Corporation HAE posted first-quarter fiscal 2027 adjusted earnings of $1.14 per share, up 3.6% year over year. The figure beat the Zacks Consensus Estimate by 6.5%. On a GAAP basis, earnings per share were 72 cents compared with 70 cents in the prior-year …

Agnico Eagle (NYSE:AEM): A High-Growth Leader with Strong Momentum

Assenagon Asset Management S.A. Sells 142,292 Shares of Haemonetics Corporation $HAE

Assenagon Asset Management S.A. significantly reduced its stake in Haemonetics Corporation (NYSE:HAE) by selling 142,292 shares, an 80.2% reduction, leaving them with 35,109 shares valued at $2.6 million. Despite this, institutional investors collectively own 99.67% of HAE, and analyst sentiment remains positive with a …

Aemetis (AMTX) Q2 2026 Earnings Call Transcript

Aemetis (AMTX) reported a significant financial turnaround in Q2 2026, achieving positive operating income and adjusted EBITDA due to growth in its California Ethanol and Dairy Renewable Natural Gas segments and the recognition of Section 45Z production tax credits. The company is advancing energy …

Agnico-Eagle Mines Ltd. stock falls Thursday, underperforms market

Agnico-Eagle Mines Ltd. (AEM) shares dropped 2.44% on Thursday, closing at C$251.52. This performance underperformed the broader Canadian market, with the S&P/TSX Composite Index rising 0.26%. The stock is also 27.9% below its 52-week high of C$348.94 achieved on March 2nd.

Braemar sells Key West resort for $190M amid shift to self-managed REIT

This story was originally published on Hotel Dive. To receive daily news and insights, subscribe to our free daily Hotel Dive newsletter. Dive Brief: Braemar Hotels & Resorts has sold the luxury Pier House Resort & Spa in Key West, Florida, to global investment …

BofA Securities Adjusts Price Target on Haemonetics to $100 From $93

BofA Securities has increased its price target for Haemonetics (HAE) to $100, up from the previous $93. This adjustment reflects a positive outlook from the firm on the medical technology company. Haemonetics specializes in solutions for critical medical needs, including hospital technologies, plasma collection, …

Haemonetics (HAE) Q1 2027 Earnings Call Transcript

Image source: The Motley Fool. DATE Thursday, Aug. 6, 2026 at 8 a.m. ET CALL PARTICIPANTS Vice President, Investor Relations and Treasurer - Olga GuyetteChief Executive Officer - Christopher SimonChief Financial Officer - James D'Arecca TAKEAWAYS Net Revenue -- $339.4 million, representing 5.6% reported …

5 Insightful Analyst Questions From Haemonetics’s Q2 Earnings Call

5 Insightful Analyst Questions From Haemonetics's Q2 Earnings Call Haemonetics delivered a Q2 performance that surpassed Wall Street's revenue and adjusted earnings expectations, supported by consistent execution across its business lines. Management attributed the quarter's results to strong innovation and commercial momentum, particularly in …

Agnico Eagle Mines Stock Surges 27%, With A 8-Day Winning Spree

Haemonetics Corporation (NYSE:HAE) Receives Average Rating of "Moderate Buy" from Analysts

Haemonetics Corporation (NYSE:HAE) has received a consensus "Moderate Buy" rating from eleven research firms, with an average 12-month price target of $90.89. The company recently surpassed quarterly expectations, reporting $1.14 EPS and $339.38 million in revenue, leading several analysts to raise their price targets …

8 Green Days In A Row: Agnico Eagle Mines Stock Is Up 27%

Haemonetics Corp (HAE) Stock Up 4.7% but GF Value Says Overvalued -- GF Score: 77/100

Haemonetics Corp (HAE) shares increased by 4.7% to $91.34, approaching its 52-week high, with significant short-term and long-term momentum. Despite this rise, GuruFocus's GF Value™ indicates the stock is overvalued by 7.6% compared to its estimate of $84.90, suggesting no margin of safety for …

Agnico Eagle Mines (AEM) sets $3.00 per Right contingent payout on Rupert deal

Agnico Eagle Mines (AEM) has established a Contingent Value Rights (CVR) Agreement in connection with its acquisition of Rupert Resources, authorizing up to 207,654,166 Rights. Each Right offers a potential payout of up to $3.00 in cash, distributed in three $1.00 tranches upon the …

AQR Capital discloses 4.99% Haemonetics Corp (HAE) position in Schedule 13G/A

AQR Capital Management, LLC and its parent, AQR Capital Management Holdings, LLC, have disclosed a beneficial ownership of 4.99% in Haemonetics Corp (HAE) common stock. This position, totaling 2,266,489 shares, was reported in a Schedule 13G/A filing as of June 30, 2026. The entities …

Agnico Eagle (AEM) Stock Trades At A Discount On Earnings But Near Fair Value On Cash Flow

Annex Advisory Services LLC Grows Stock Holdings in Agnico Eagle Mines Limited $AEM

Quantinno Capital Management LP Has $1.73 Million Stock Holdings in Haemonetics Corporation $HAE

Quantinno Capital Management LP significantly increased its stake in Haemonetics Corporation (NYSE:HAE) by 438% in the first quarter, bringing its total holdings to 30,708 shares valued at $1.73 million. Haemonetics reported strong quarterly results, beating analyst expectations with $339.38 million in revenue and $1.14 …

Agnico Eagle Mines (AEM) On Earnings Dividend And Buybacks Still Leaves A Valuation Question

Make better investment decisions with Simply Wall St's easy, visual tools that give you a competitive edge. Earnings, dividend and buyback activity put Agnico Eagle Mines (NYSE:AEM) in focus Agnico Eagle Mines (NYSE:AEM) has drawn fresh investor attention after releasing second quarter 2026 results, …

Agnico Eagle Mines (AEM) Is Up 20.7% After EPS Jumps Despite Lower Gold Output And Buybacks

In late July 2026, Agnico Eagle Mines reported second-quarter results showing slightly lower gold production year over year but a sharp increase in net income and earnings per share, while also guiding full-year 2026 output toward the lower end of its 3.3–3.5 million-ounce range …

Does Strong Q1 Results And VASCADE Data Shift The Bull Case For Haemonetics (HAE)?

Haemonetics Corporation reported stronger-than-expected Q1 results with increased sales and diluted EPS, along with positive new Emory University study data reinforcing the safety and efficiency of its VASCADE MVP XL venous vascular closure system. These developments, particularly the VASCADE data, are seen as significant …

Agnico Eagle Mines (AEM) Stock Looks Fairly Priced On Cash Flow But Cheap On Earnings

Track your investments for FREE with Simply Wall St, the portfolio command center trusted by over 7 million individual investors worldwide. Agnico Eagle Mines stock has delivered a very large 3 year return, while current valuation checks suggest it is closer to fairly valued …

ETFs Investing in Braemar Hotels & Resorts, Inc. 5.5 % Cum Conv Pfd Registered Shs Series B Stocks

This article lists Exchange Traded Funds (ETFs) that invest in Braemar Hotels & Resorts, Inc. 5.5% Series B Cumulative Convertible Preferred Stock. It provides a table of funds including their market value, weight, issuer, management style, expense ratio, AUM, price, change percentage, relative volume, …

Haemonetics stock hits 52-week high at 88.73 USD

Haemonetics Corp's stock reached a new 52-week high of $88.73, marking a significant 67.34% increase over the past year and reflecting strong investor confidence. The medical technology company's market capitalization stands at $3.97 billion, with its P/E ratio of 42 suggesting it may be …

Can Agnico Eagle Keep Earnings Shining Amid Cost Pressures?

Agnico Eagle Mines Limited AEM delivered better-than-expected earnings in the second quarter on higher realized gold prices, but it remains mired in headwinds from higher costs. Its all-in sustaining costs (AISC) — the most important cost metric of miners — were $1,459 per ounce …

Haemonetics (HAE) Reliance on International Sales: What Investors Need to Know

Have you looked into how Haemonetics (HAE) performed internationally during the quarter ending June 2026? Considering the widespread global presence of this provider blood management systems for health care providers and blood collectors, examining the trends in international revenues is essential for assessing its …

Renaissance Technologies LLC Takes $2.44 Million Position in Haemonetics Corporation $HAE

Renaissance Technologies LLC has acquired a new position in Haemonetics Corporation, purchasing 43,200 shares valued at approximately $2.44 million. Haemonetics maintains a "Moderate Buy" consensus rating from analysts, with an average price target of $90.89, following strong quarterly earnings that surpassed expectations. Institutional investors …

Could Agnico Eagle (TSX:AEM) Keep Growth Stocks Shining Longer?

Aemetis posts 2Q26 profit growth with 20% revenue rise, driven by higher RNG and ethanol gains.

Aemetis Inc. reported a 20% year-over-year revenue increase to $62.7 million in Q2 2026, achieving a gross profit of $13.5 million and adjusted EBITDA of $9.7 million. This growth was driven by higher renewable natural gas (RNG) production and improved ethanol economics, despite ongoing …

Stonegate Capital Partners Updates Coverage on Aemetis Inc. (AMTX) 2Q26

Stonegate Capital Partners has updated its coverage on Aemetis Inc. (AMTX) for Q2 2026, highlighting significant operational improvements. The company saw a 20% year-over-year revenue increase to $62.7M and achieved positive operating income and adjusted EBITDA due to 45Z recognition, higher RNG production, and …

AEM Stock Pops 25% in a Month: What Should Investors Do Now?

Agnico Eagle Mines Limited's AEM shares have rallied 24.6% in the past month, thanks to a rebound in gold prices and the company's forecast-topping earnings performance in the second quarter driven by higher realized prices. AEM saw 35% and 57% year-over-year growth in its …

Aemetis Inc. (AMTX) 2Q26 Coverage Update: Revenue Jumps 20% as Dairy RNG and Ethanol Economics Drive Operating Inflection

Stonegate Capital Partners updated its coverage on Aemetis Inc. (AMTX), noting a significant operating inflection in 2Q26 with revenue increasing 20% year-over-year to $62.7 million and adjusted EBITDA turning positive. This growth was primarily driven by dairy Renewable Natural Gas (RNG) sales volumes and …